初始喉罩置入与气管插管策略对院外心脏骤停成人72小时生存率的影响:一项随机临床试验
该多中心实用整群交叉随机临床试验纳入3004例院外心脏骤停且预期需要高级气道管理的成人,比较初始喉罩置入策略(n=1505)与初始气管插管策略(n=1499),每3至5个月交叉。主要终点72小时生存率喉罩组18.3% vs 气管插管组15.4%(校正差值2.9%,95%CI 0.2%-5.6%,P=0.04)。次要终点包括自主循环恢复(27.9% vs 24.3%)、出院生存(10.8% vs 8.1%)和出院时良好神经功能(7.1% vs 5.0%),均有利于喉罩组。作者认为喉罩置入可考虑作为院外心脏骤停患者的初始气道管理策略,但实用设计、实践场所和气管插管操作特性等局限性提示需进一步研究。
要点
- 院外心脏骤停成人初始喉罩置入策略72小时生存率18.3%,初始气管插管策略15.4%(校正差值2.9%,95%CI 0.2%-5.6%,P=0.04)。
- 初始气道成功率喉罩组90.3%,气管插管组51.6%。
- 出院生存喉罩组10.8% vs 气管插管组8.1%(校正差值2.7%,95%CI 0.6%-4.8%,P=0.01)。
- 出院时良好神经功能(改良Rankin量表评分≤3)喉罩组7.1% vs 气管插管组5.0%(校正差值2.1%,95%CI 0.3%-3.8%,P=0.02)。
- 作者认为喉罩置入可考虑作为院外心脏骤停患者的初始气道管理策略,但实用设计等局限性提示需进一步研究。
适用人群与场景
- 院外心脏骤停成人,预期需要高级气道管理,2015年12月1日至2017年11月4日入组,来自复苏结局联盟的急救医疗服务机构。
处置流程与药物剂量
- 初始气道管理策略为喉罩置入或气管插管,急救医疗服务机构按整群随机分配,每3至5个月交叉至另一策略。
研究设计与关键结果
- 多中心实用整群交叉随机临床试验,纳入3004例院外心脏骤停成人(中位年龄64岁,四分位距53-76岁;男性1829例,占60.9%),3000例纳入主要分析;27个急救医疗服务机构随机分为13个集群,喉罩组1505例,气管插管组1499例。
- 主要终点72小时生存率:喉罩组18.3% vs 气管插管组15.4%(校正差值2.9%,95%CI 0.2%-5.6%,P=0.04)。
- 初始气道成功率:喉罩组90.3% vs 气管插管组51.6%。
- 自主循环恢复:喉罩组27.9% vs 气管插管组24.3%(校正差值3.6%,95%CI 0.3%-6.8%,P=0.03)。
- 出院生存:喉罩组10.8% vs 气管插管组8.1%(校正差值2.7%,95%CI 0.6%-4.8%,P=0.01)。
- 出院时良好神经功能(改良Rankin量表评分≤3):喉罩组7.1% vs 气管插管组5.0%(校正差值2.1%,95%CI 0.3%-3.8%,P=0.02)。
- 口咽或下咽损伤(0.2% vs 0.3%)、气道肿胀(1.1% vs 1.0%)、肺炎或肺炎症(26.1% vs 22.3%)无显著差异。
证据类型、等级与局限
- 证据类型:多中心实用整群交叉随机临床试验。
- 局限:原文指出实用设计、实践场所和气管插管操作特性存在局限性,提示需进一步研究。
对床旁实践的改变
- 在院外心脏骤停成人中,初始喉罩置入策略较初始气管插管策略72小时生存率更高(18.3% vs 15.4%)。
- 作者认为喉罩置入可考虑作为院外心脏骤停患者的初始气道管理策略,但实用设计、实践场所和气管插管操作特性等局限性提示需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Emergency medical services (EMS) commonly perform endotracheal intubation (ETI) or insertion of supraglottic airways, such as the laryngeal tube (LT), on patients with out-of-hospital cardiac arrest (OHCA). The optimal method for OHCA advanced airway management is unknown.
OBJECTIVE: To compare the effectiveness of a strategy of initial LT insertion vs initial ETI in adults with OHCA.
DESIGN, SETTING, AND PARTICIPANTS: Multicenter pragmatic cluster-crossover clinical trial involving EMS agencies from the Resuscitation Outcomes Consortium. The trial included 3004 adults with OHCA and anticipated need for advanced airway management who were enrolled from December 1, 2015, to November 4, 2017. The final date of follow-up was November 10, 2017.
INTERVENTIONS: Twenty-seven EMS agencies were randomized in 13 clusters to initial airway management strategy with LT (n = 1505 patients) or ETI (n = 1499 patients), with crossover to the alternate strategy at 3- to 5-month intervals.
MAIN OUTCOMES AND MEASURES: The primary outcome was 72-hour survival. Secondary outcomes included return of spontaneous circulation, survival to hospital discharge, favorable neurological status at hospital discharge (Modified Rankin Scale score ≤3), and key adverse events.
RESULTS: Among 3004 enrolled patients (median [interquartile range] age, 64 [53-76] years, 1829 [60.9%] men), 3000 were included in the primary analysis. Rates of initial airway success were 90.3% with LT and 51.6% with ETI. Seventy-two hour survival was 18.3% in the LT group vs 15.4% in the ETI group (adjusted difference, 2.9% [95% CI, 0.2%-5.6%]; P = .04). Secondary outcomes in the LT group vs ETI group were return of spontaneous circulation (27.9% vs 24.3%; adjusted difference, 3.6% [95% CI, 0.3%-6.8%]; P = .03); hospital survival (10.8% vs 8.1%; adjusted difference, 2.7% [95% CI, 0.6%-4.8%]; P = .01); and favorable neurological status at discharge (7.1% vs 5.0%; adjusted difference, 2.1% [95% CI, 0.3%-3.8%]; P = .02). There were no significant differences in oropharyngeal or hypopharyngeal injury (0.2% vs 0.3%), airway swelling (1.1% vs 1.0%), or pneumonia or pneumonitis (26.1% vs 22.3%).
CONCLUSIONS AND RELEVANCE: Among adults with OHCA, a strategy of initial LT insertion was associated with significantly greater 72-hour survival compared with a strategy of initial ETI. These findings suggest that LT insertion may be considered as an initial airway management strategy in patients with OHCA, but limitations of the pragmatic design, practice setting, and ETI performance characteristics suggest that further research is warranted.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02419573.
参考来源
- Wang HE, Schmicker RH, Daya MR, et al. Effect of a Strategy of Initial Laryngeal Tube Insertion vs Endotracheal Intubation on 72-Hour Survival in Adults With Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2018. PMID: 30167699. doi:10.1001/jama.2018.7044
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。